Supra-annular mitral valve implantation in very small children

Raffaele Giordano1, Massimiliano Cantinotti, Vitali Pak

  • 1Pediatric Cardiac Surgery, The Heart Hospital, Tuscany Foundation "Gabriele Monasterio", Massa, Italy.

Journal of Cardiac Surgery
|December 30, 2014
PubMed

Insights

Mitral valve replacement in very young children offers acceptable outcomes, but complications like thrombotic events require careful monitoring. This surgical option is feasible when other procedures fail.

Area of Science:

  • Pediatric Cardiac Surgery
  • Cardiovascular Surgery
  • Mechanical Valve Prostheses

Background:

  • Mitral valve replacement (MVR) is an alternative when mitral valvuloplasty is not feasible or successful.
  • Very young children with mitral valve disease present unique surgical challenges.

Purpose of the Study:

  • To review the experience with supra-annular MVR using mechanical prostheses in very young children.
  • To evaluate the feasibility and outcomes of MVR in this pediatric population.

Main Methods:

  • Seven children (4-35 months) underwent MVR with mechanical prostheses in the supra-annular position.
  • A biatrial transeptal incision was used for improved surgical exposure.
  • Patients had congenital or rheumatic mitral valve defects, with most having prior cardiac procedures.

Main Results:

  • All patients received CarboMedics mechanical prostheses without operative or late mortality.
  • Follow-up revealed two patients (28.6%) required reoperation due to thrombotic pannus formation.
  • One patient needed prosthesis replacement due to complications.

Conclusions:

  • Supra-annular MVR is a feasible secondary option for children with small mitral annuli when valvuloplasty is unsuitable.
  • Early and mid-term outcomes are acceptable, but thrombotic complications are a concern.
  • Careful patient selection and monitoring are essential for successful MVR in pediatric cases.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
488
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.6K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
545
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
627
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.0K
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.3K